多模式治疗肝细胞肝癌的共识与争议
李相成;李长贤;张嘉伟;沈浩
【期刊名称】《中国实用外科杂志》 【年(卷),期】2018(038)001
【摘要】With the development of medical technology,the treatment of hepatocellular carcinoma (HCC) has developed into a multidisciplinary and multimodal treatment model.At present,there are many treatments for
HCC,including
surgical
resection,liver
transplantation,ablation,transarterial
chemoembolization,radioembolization,molecular
targeted
therapy,chemotherapy,immunotherapy and so on.To improve the overall curative effect of HCC,the treatment plan should be formulated according
to
different
individuals
by
using
multidisciplinary
advantages.At present,surgery is still the best radical treatment for the patients with resectable HCC.Comprehensive treatment can be an important supplement to surgical treatment,which increase the chance of surgical resection and reduce postoperative recurrence and metastasis,and provide a good treatment opportunity for advanced HCC patients,and prolong the survival of patients.%随着医疗技术的进步,肝细胞肝癌的治疗已经进入多学科、多模式共存阶段.针对肝癌的治疗方法有很多种,包括手术切除、肝移植、动脉化疗栓塞、消融、分子靶向药物治疗、放疗、化疗、免疫治疗等.应根据不同个体制定相应治疗方案,利用多学科优势,提高肝
多模式治疗肝细胞肝癌的共识与争议
